Altimmune, Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
ALT on Nasdaq
Location
910 Clopper Road, Suite 201 S, Gaithersburg, MD

Insiders trading volume in the past year

Altimmune, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Vipin K. Garg President and CEO, Director $2.36M Jan 30, 2025
Matthew Scott Harris Chief Medical Officer $544K Jan 30, 2025
M. Scot Roberts Chief Scientific Officer $486K Jan 30, 2025
Richard I. Eisenstadt Chief Financial Officer $441K Jan 30, 2024
David Drutz Director $382K -$111K -22.4% Aug 19, 2024
William Michael Brown Chief Financial Officer $199K Jul 31, 2021
Raymond M. Jordt Chief Business Officer $181K Jan 31, 2025
Andrew Shutterly Acting Chief Financial Officer $61.5K Jul 31, 2024
Mitchel Sayare Director Sep 26, 2024
Catherine A. Sohn Director Feb 6, 2025
Gregory L. Weaver Chief Financial Officer Nov 11, 2024
Philip Hodges Director Sep 26, 2024
Wayne Pisano Director Sep 26, 2024
Klaus Schafer Director Sep 26, 2024
John Gill Director Sep 26, 2024
Diane Jorkasky Director Sep 26, 2024

Recent Insider Transactions by Companies or Individuals for Altimmune, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.